
|Articles|September 1, 2001
Engineered Tissue Successfully Heals Diabetic Ulcers Over 12 Weeks
NEW YORK - OrCel, an engineered tissue produced by Ortec International, showed greater than 100 percent improvement over standard of care in diabetic ulcers the size of 6 cm2 or less,according to interim 12-week clinical data from a trial pilot conducted by the company.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
5














